Investment ratings houses cool on Sigma/CWH deal

fridge cold chain medicines
Evidence is growing that some institutional advisors may be starting to grow wary of the CWH/Sigma deal, says Mike Taylor   When financial advisers make investment recommendations to clients they are highly reliant on the assessments of research and ratings organisations such as Morningstar and, right now, those ratings houses remain to be convinced about the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Lengthy use underscores need for early assessment
Next New database to support evolution of pharmacy